The global metabolomics reagents market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for personalized medicine and the growing number of research studies in metabolomics. The global metabolomics reagents market by type is segmented into glycometabolism, amino acid metabolism, fatty acid/cholesterol metabolism. The glycometabolism segment accounted for the largest share in 2018 and it is expected to continue its dominance throughout the forecast period due to its wide application in diabetes research. The amino acid metabolism segment accounted for a significant share in 2018 and it is expected to grow at a CAGR of 13% during the forecast period due to its wide application in obesity research. The fatty acid/cholesterol metabolism segment accounted for a small share in 2018 but it will grow at an impressive CAGR of 16% during the forecast period due to its wide application in cardiovascular diseases research. The global metabolomics reagents market by application includes diabetes, obesity, cardiovascular diseases and others (cancer). Diabetes was one of the leading applications accounting for over 40% share followed by obesity with over 30%. Cardiovascular diseases was one of other applications which accounted for less than 10%.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic diseases such as diabetes and obesity is driving the growth of the metabolomics reagents market.
- The increasing demand for personalized medicine is also driving the growth of the metabolomics reagents market.
- The growing number of research studies on metabolic disorders is expected to drive the growth of this market in future years.
- Increasing awareness about metabolic disorders among patients and healthcare providers will also drive this market in future years 5.Increasing funding for research on metabolic disorders will also fuel this market.
Industry Growth Insights published a new data on “Metabolomics Reagents Market”. The research report is titled “Metabolomics Reagents Market research by Types (Glycometabolism, Amino Acid Metabolism, Fatty Acid/Cholesterol Metabolism, Others), By Applications (Diabetes, Obesity, Others), By Players/Companies BioVision, Merck, Thermo Fisher Scientific, BD, Abbott, Kerafast, Beijing Strong Biotechnologies, Pointe Scientific, Luxcel Biosciences, Randox Laboratories Limited, Beijing Leadman Biochemistry, Shenzhen Bioeasy Biotechnology, Shenzhen Lvshiyuan Biotechnology, BioSino, NITTO BOSEKI”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Metabolomics Reagents Market Research Report
By Type
Glycometabolism, Amino Acid Metabolism, Fatty Acid/Cholesterol Metabolism, Others
By Application
Diabetes, Obesity, Others
By Companies
BioVision, Merck, Thermo Fisher Scientific, BD, Abbott, Kerafast, Beijing Strong Biotechnologies, Pointe Scientific, Luxcel Biosciences, Randox Laboratories Limited, Beijing Leadman Biochemistry, Shenzhen Bioeasy Biotechnology, Shenzhen Lvshiyuan Biotechnology, BioSino, NITTO BOSEKI
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Metabolomics Reagents Market Report Segments:
The global Metabolomics Reagents market is segmented on the basis of:
Types
Glycometabolism, Amino Acid Metabolism, Fatty Acid/Cholesterol Metabolism, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes, Obesity, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BioVision
- Merck
- Thermo Fisher Scientific
- BD
- Abbott
- Kerafast
- Beijing Strong Biotechnologies
- Pointe Scientific
- Luxcel Biosciences
- Randox Laboratories Limited
- Beijing Leadman Biochemistry
- Shenzhen Bioeasy Biotechnology
- Shenzhen Lvshiyuan Biotechnology
- BioSino
- NITTO BOSEKI
Highlights of The Metabolomics Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glycometabolism
- Amino Acid Metabolism
- Fatty Acid/Cholesterol Metabolism
- Others
- By Application:
- Diabetes
- Obesity
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Metabolomics Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Metabolomics reagents are used to identify and quantify the metabolites of a sample.
Some of the major companies in the metabolomics reagents market are BioVision, Merck, Thermo Fisher Scientific, BD, Abbott, Kerafast, Beijing Strong Biotechnologies, Pointe Scientific, Luxcel Biosciences, Randox Laboratories Limited, Beijing Leadman Biochemistry, Shenzhen Bioeasy Biotechnology, Shenzhen Lvshiyuan Biotechnology, BioSino, NITTO BOSEKI.
The metabolomics reagents market is expected to register a CAGR of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Metabolomics Reagents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Metabolomics Reagents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Metabolomics Reagents Market - Supply Chain
4.5. Global Metabolomics Reagents Market Forecast
4.5.1. Metabolomics Reagents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Metabolomics Reagents Market Size (000 Units) and Y-o-Y Growth
4.5.3. Metabolomics Reagents Market Absolute $ Opportunity
5. Global Metabolomics Reagents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Metabolomics Reagents Market Size and Volume Forecast by Type
5.3.1. Glycometabolism
5.3.2. Amino Acid Metabolism
5.3.3. Fatty Acid/Cholesterol Metabolism
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Metabolomics Reagents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Metabolomics Reagents Market Size and Volume Forecast by Application
6.3.1. Diabetes
6.3.2. Obesity
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Metabolomics Reagents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Metabolomics Reagents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Metabolomics Reagents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Metabolomics Reagents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Metabolomics Reagents Demand Share Forecast, 2019-2026
9. North America Metabolomics Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Metabolomics Reagents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Metabolomics Reagents Market Size and Volume Forecast by Application
9.4.1. Diabetes
9.4.2. Obesity
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Metabolomics Reagents Market Size and Volume Forecast by Type
9.7.1. Glycometabolism
9.7.2. Amino Acid Metabolism
9.7.3. Fatty Acid/Cholesterol Metabolism
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Metabolomics Reagents Demand Share Forecast, 2019-2026
10. Latin America Metabolomics Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Metabolomics Reagents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Metabolomics Reagents Market Size and Volume Forecast by Application
10.4.1. Diabetes
10.4.2. Obesity
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Metabolomics Reagents Market Size and Volume Forecast by Type
10.7.1. Glycometabolism
10.7.2. Amino Acid Metabolism
10.7.3. Fatty Acid/Cholesterol Metabolism
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Metabolomics Reagents Demand Share Forecast, 2019-2026
11. Europe Metabolomics Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Metabolomics Reagents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Metabolomics Reagents Market Size and Volume Forecast by Application
11.4.1. Diabetes
11.4.2. Obesity
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Metabolomics Reagents Market Size and Volume Forecast by Type
11.7.1. Glycometabolism
11.7.2. Amino Acid Metabolism
11.7.3. Fatty Acid/Cholesterol Metabolism
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projctions by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Metabolomics Reagents Demand Share, 2019-2026
12. Asia Pacific Metabolomics Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Metabolomics Reagents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Metabolomics Reagents Market Size and Volume Forecast by Application
12.4.1. Diabetes
12.4.2. Obesity
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Metabolomics Reagents Market Size and Volume Forecast by Type
12.7.1. Glycometabolism
12.7.2. Amino Acid Metabolism
12.7.3. Fatty Acid/Cholesterol Metabolism
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Metabolomics Reagents Demand Share, 2019-2026
13. Middle East & Africa Metabolomics Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Metabolomics Reagents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Metabolomics Reagents Market Size and Volume Forecast by Application
13.4.1. Diabetes
13.4.2. Obesity
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Metabolomics Reagents Market Size and Volume Forecast by Type
13.7.1. Glycometabolism
13.7.2. Amino Acid Metabolism
13.7.3. Fatty Acid/Cholesterol Metabolism
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Metabolomics Reagents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Metabolomics Reagents Market: Market Share Analysis
14.2. Metabolomics Reagents Distributors and Customers
14.3. Metabolomics Reagents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BioVision
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BD
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbott
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Kerafast
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Beijing Strong Biotechnologies
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pointe Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Luxcel Biosciences
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Randox Laboratories Limited
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Beijing Leadman Biochemistry
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Shenzhen Bioeasy Biotechnology
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Shenzhen Lvshiyuan Biotechnology
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. BioSino
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. NITTO BOSEKI
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook